Processa Pharmaceuticals, Inc.
PCSA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001533743
No open-market purchases or sales by Processa Pharmaceuticals, Inc. insiders were filed in the last 90 days; 12 institutions reported holding it in 13F filings for Q2 2026, worth $498.3K in total; no superinvestor holds it.
Q1 2025 vs. Q4 2024
How the institutions holding Processa Pharmaceuticals, Inc. changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Q1 2025 | Change |
|---|---|---|---|
| Holders | 8 | 9 | +1 |
| Shares | 98.9K | 170.8K | +71.9K (+72.6%) |
| Value | $87.5K | $63.2K | −$24.3K (−27.8%) |
New holders (2)
Institutions that held Processa Pharmaceuticals, Inc. at the end of Q1 2025 but not at the end of Q4 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Armistice Capital, LLC | 56,000 | $20.7K | 0.00% |
| Virtu Financial LLC | 43,229 | $16.0K | 0.00% |
Sold out (1)
Institutions that held Processa Pharmaceuticals, Inc. at the end of Q4 2024 and filed for Q1 2025 without it.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| HRT Financial LP | 31,971 | $28.0K |